Cargando…

PD-1/PD-L1 and DNA Damage Response in Cancer

The application of immunotherapy for cancer treatment is rapidly becoming more widespread. Immunotherapeutic agents are frequently combined with various types of treatments to obtain a more durable antitumor clinical response in patients who have developed resistance to monotherapy. Chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kciuk, Mateusz, Kołat, Damian, Kałuzińska-Kołat, Żaneta, Gawrysiak, Mateusz, Drozda, Rafał, Celik, Ismail, Kontek, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954559/ https://www.ncbi.nlm.nih.gov/pubmed/36831197 http://dx.doi.org/10.3390/cells12040530

Ejemplares similares

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
por: Kciuk, Mateusz, et al.
Publicado: (2023)

Substances of Natural Origin in Medicine: Plants vs. Cancer
por: Gielecińska, Adrianna, et al.
Publicado: (2023)

Pyroptosis-related signatures in bladder cancer prognosis and treatment—are we there yet?
por: Kołat, Damian, et al.
Publicado: (2022)

AP-2δ Is the Most Relevant Target of AP-2 Family-Focused Cancer Therapy and Affects Genome Organization
por: Kołat, Damian, et al.
Publicado: (2022)

The artificial oxygen carrier erythrocruorin—characteristics and potential significance in medicine
por: Kruczkowska, Weronika, et al.
Publicado: (2023)

Do selected lifestyle parameters affect the severity and symptoms of COVID-19 among elderly patients? The retrospective evaluation of individuals from the STOP-COVID registry of the PoLoCOV study
por: Kapusta, Joanna, et al.
Publicado: (2023)

Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
por: Chudzik, Michał, et al.
Publicado: (2022)

Antineoplastic Nature of WWOX in Glioblastoma Is Mainly a Consequence of Reduced Cell Viability and Invasion
por: Kałuzińska-Kołat, Żaneta, et al.
Publicado: (2023)

Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations
por: Kałuzińska-Kołat, Żaneta, et al.
Publicado: (2023)

Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
por: Kałuzińska-Kołat, Żaneta, et al.
Publicado: (2023)

Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up
por: Babicki, Mateusz, et al.
Publicado: (2023)

LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer
por: Kołat, Damian, et al.
Publicado: (2023)

Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
por: Kciuk, Mateusz, et al.
Publicado: (2022)

Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry of the PoLoCOV-Study
por: Chudzik, Michał, et al.
Publicado: (2022)

The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers
por: Kołat, Damian, et al.
Publicado: (2019)

Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

Corrigendum: Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

WWOX Loses the Ability to Regulate Oncogenic AP-2γ and Synergizes with Tumor Suppressor AP-2α in High-Grade Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

PLEK2, RRM2, GCSH: A Novel WWOX-Dependent Biomarker Triad of Glioblastoma at the Crossroads of Cytoskeleton Reorganization and Metabolism Alterations
por: Kałuzińska, Żaneta, et al.
Publicado: (2021)

Prognostic significance of AP-2α/γ targets as cancer therapeutics
por: Kołat, Damian, et al.
Publicado: (2022)

Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2022)

Focus on UV-Induced DNA Damage and Repair—Disease Relevance and Protective Strategies
por: Kciuk, Mateusz, et al.
Publicado: (2020)

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
por: Kciuk, Mateusz, et al.
Publicado: (2022)

Functional genomics of AP-2α and AP-2γ in cancers: in silico study
por: Kołat, Damian, et al.
Publicado: (2020)

MicroRNAs: Their Role in Metastasis, Angiogenesis, and the Potential for Biomarker Utility in Bladder Carcinomas
por: Hammouz, Raneem Y., et al.
Publicado: (2021)

Advances in DNA Repair—Emerging Players in the Arena of Eukaryotic DNA Repair
por: Kciuk, Mateusz, et al.
Publicado: (2020)

In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer
por: Kałuzińska, Żaneta, et al.
Publicado: (2021)

Carboxymethyl Chitosan Hydrogels for Effective Wound Healing—An Animal Study
por: Kłosiński, Karol Kamil, et al.
Publicado: (2023)

Whether and what abnormalities we find in ECG records and 24-hour Holter ECG in patients after COVID-19 without hospitalization with cardiac damage
por: Chudzik, M, et al.
Publicado: (2023)

Biocompatibility and Mechanical Properties of Carboxymethyl Chitosan Hydrogels
por: Kłosiński, Karol K., et al.
Publicado: (2022)

Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
por: Kciuk, Mateusz, et al.
Publicado: (2020)

Mechanisms of Multidrug Resistance in Cancer Chemotherapy
por: Bukowski, Karol, et al.
Publicado: (2020)

Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro
por: Bukowski, Karol, et al.
Publicado: (2022)

Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as an Important Scaffold for Anticancer Drug Discovery—In Vitro and In Silico Evaluation
por: Kciuk, Mateusz, et al.
Publicado: (2023)

Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Apoptosis, Oxidative Stress, and Cell Cycle Analysis
por: Bukowski, Karol, et al.
Publicado: (2023)

Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
por: Chudzik, M, et al.
Publicado: (2023)

Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies
por: Kciuk, Mateusz, et al.
Publicado: (2022)

Genotoxicity of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides in Normal and Cancer Cells In Vitro
por: Kciuk, Mateusz, et al.
Publicado: (2023)

Metastasis and MAPK Pathways
por: Kciuk, Mateusz, et al.
Publicado: (2022)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
por: Zhang, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2p373361c6oq5u55fborl0gp4